3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Weight Loss
2
Stomach Neoplasms
1
Psoriasis
1
Osteoarthritis
1
Neoplasms
1
Muscular Atrophy
1
Muscle Weakness
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Chronic-Phase
1
Colitis, Ulcerative
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Cancer Cachexia
1
Cachexia
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Anorexia
1
Interventions
Etanercept
3
Methotrexate
2
Adalimumab
2
secukinumab
1
purine
1
fumaric acid
1
deucravacitinib
1
apremilast
1
Vitamin D
1
Vaccines
1
Sulfasalazine
1
Standard of Care
1
Saline Solution
1
Practice Guidelines as Topic
1
Nivolumab
1
Methods
1
Mesalamine
1
Mercaptopurine
1
Interviews as Topic
1
Infliximab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Educational Status
1
Eating
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Psoriasis
×
Eicosapentaenoic Acid
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts